Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients
The clinical assessment of spasticity in stroke patients generally includes descriptive scales, such as the Modified Ashworth Scale (MAS) and the Global Pain Scale (GPS), however these may not be sufficiently sensitive to accurately detect improvements, especially at upper limb level; electromyograp...
Gespeichert in:
| Veröffentlicht in: | Functional neurology 2010-04, Vol.25 (2), p.103-107 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 107 |
|---|---|
| container_issue | 2 |
| container_start_page | 103 |
| container_title | Functional neurology |
| container_volume | 25 |
| creator | Albani, Giovanni Cimolin, Veronica Galli, Manuela Vimercati, Sara Bar, Daniela Campanelli, Laura Gandolfi, Roberto Lombardi, Remo Mauro, Alessandro |
| description | The clinical assessment of spasticity in stroke patients generally includes descriptive scales, such as the Modified Ashworth Scale (MAS) and the Global Pain Scale (GPS), however these may not be sufficiently sensitive to accurately detect improvements, especially at upper limb level; electromyography (EMG) may be the answer to this clinical requirement. The aim of this study was to quantify the effects of botulinum toxin type A (BTX) in treating upper extremity spasticity in stroke patients, using clinical evaluation (MAS and GPS) and EMG. Ten patients were assessed before, 30 days and 180 days after BTX injection using clinical evaluations and EMG. At 30 days all clinical measures improved significantly. Whereas MAS scores, after recording an improvement at the first evaluation session, were worse at the second assessment, GPS scores improved over time, both at the first and at the second evaluation session. A reduction of EMG activity was found 30 days after injections, in particular at baseline and during passive flexion movement. Our results demonstrated that measurement of EMG activity may be an effective means of detecting functional improvements and of monitoring the effects of treatment in post-stroke patients. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_756823255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>756823255</sourcerecordid><originalsourceid>FETCH-LOGICAL-p237t-2f7e28567668d10019f76a99bd572e88093f26b7cb00f46cf0f914d00675923f3</originalsourceid><addsrcrecordid>eNpd0E1LxDAQBuAgiltX_4IEL54KadJ8HWVZV2HFi3suaZto1raJ-RD331txvXiagXl4mZkTUFSSVyXBvD4FBSKSlBSzegEuYtwjRAmp0TlYYCQxYUgUYNhFDZ2BMQejOg3XTxtoXID6Uw1ZJeumn2n2Xgc42LGF0auYbGfTAfY52OkVti7lwU55hMl92QmmNx2UP8C5jSm4dw39HKSnFC_BmVFD1FfHugS7-_XL6qHcPm8eV3fb0mPCU4kN11hQxhkTfYVQJQ1nSsq2pxxrIZAkBrOWdy1CpmadQUZWdY8Q43S-y5AluP3N9cF9ZB1TM9rY6WFQk3Y5NpwygQmmdJY3_-Te5TDNyzUCCYpnJWZ0fUS5HXXf-GBHFQ7N3xfJN2hcbsw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>808522328</pqid></control><display><type>article</type><title>Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Albani, Giovanni ; Cimolin, Veronica ; Galli, Manuela ; Vimercati, Sara ; Bar, Daniela ; Campanelli, Laura ; Gandolfi, Roberto ; Lombardi, Remo ; Mauro, Alessandro</creator><creatorcontrib>Albani, Giovanni ; Cimolin, Veronica ; Galli, Manuela ; Vimercati, Sara ; Bar, Daniela ; Campanelli, Laura ; Gandolfi, Roberto ; Lombardi, Remo ; Mauro, Alessandro</creatorcontrib><description>The clinical assessment of spasticity in stroke patients generally includes descriptive scales, such as the Modified Ashworth Scale (MAS) and the Global Pain Scale (GPS), however these may not be sufficiently sensitive to accurately detect improvements, especially at upper limb level; electromyography (EMG) may be the answer to this clinical requirement. The aim of this study was to quantify the effects of botulinum toxin type A (BTX) in treating upper extremity spasticity in stroke patients, using clinical evaluation (MAS and GPS) and EMG. Ten patients were assessed before, 30 days and 180 days after BTX injection using clinical evaluations and EMG. At 30 days all clinical measures improved significantly. Whereas MAS scores, after recording an improvement at the first evaluation session, were worse at the second assessment, GPS scores improved over time, both at the first and at the second evaluation session. A reduction of EMG activity was found 30 days after injections, in particular at baseline and during passive flexion movement. Our results demonstrated that measurement of EMG activity may be an effective means of detecting functional improvements and of monitoring the effects of treatment in post-stroke patients.</description><identifier>ISSN: 0393-5264</identifier><identifier>EISSN: 1971-3274</identifier><identifier>PMID: 20923608</identifier><language>eng</language><publisher>Italy: CIC Edizioni Internazionali</publisher><subject>Adult ; Aged ; Botulinum Toxins, Type A - therapeutic use ; Electromyography - methods ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Muscle Spasticity - drug therapy ; Muscle Spasticity - etiology ; Neuromuscular Agents - therapeutic use ; Pain Measurement ; Range of Motion, Articular - drug effects ; Severity of Illness Index ; Stroke - complications ; Treatment Outcome ; Upper Extremity</subject><ispartof>Functional neurology, 2010-04, Vol.25 (2), p.103-107</ispartof><rights>Copyright CIC Edizioni Internatzionali Apr-Jun 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20923608$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Albani, Giovanni</creatorcontrib><creatorcontrib>Cimolin, Veronica</creatorcontrib><creatorcontrib>Galli, Manuela</creatorcontrib><creatorcontrib>Vimercati, Sara</creatorcontrib><creatorcontrib>Bar, Daniela</creatorcontrib><creatorcontrib>Campanelli, Laura</creatorcontrib><creatorcontrib>Gandolfi, Roberto</creatorcontrib><creatorcontrib>Lombardi, Remo</creatorcontrib><creatorcontrib>Mauro, Alessandro</creatorcontrib><title>Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients</title><title>Functional neurology</title><addtitle>Funct Neurol</addtitle><description>The clinical assessment of spasticity in stroke patients generally includes descriptive scales, such as the Modified Ashworth Scale (MAS) and the Global Pain Scale (GPS), however these may not be sufficiently sensitive to accurately detect improvements, especially at upper limb level; electromyography (EMG) may be the answer to this clinical requirement. The aim of this study was to quantify the effects of botulinum toxin type A (BTX) in treating upper extremity spasticity in stroke patients, using clinical evaluation (MAS and GPS) and EMG. Ten patients were assessed before, 30 days and 180 days after BTX injection using clinical evaluations and EMG. At 30 days all clinical measures improved significantly. Whereas MAS scores, after recording an improvement at the first evaluation session, were worse at the second assessment, GPS scores improved over time, both at the first and at the second evaluation session. A reduction of EMG activity was found 30 days after injections, in particular at baseline and during passive flexion movement. Our results demonstrated that measurement of EMG activity may be an effective means of detecting functional improvements and of monitoring the effects of treatment in post-stroke patients.</description><subject>Adult</subject><subject>Aged</subject><subject>Botulinum Toxins, Type A - therapeutic use</subject><subject>Electromyography - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Muscle Spasticity - drug therapy</subject><subject>Muscle Spasticity - etiology</subject><subject>Neuromuscular Agents - therapeutic use</subject><subject>Pain Measurement</subject><subject>Range of Motion, Articular - drug effects</subject><subject>Severity of Illness Index</subject><subject>Stroke - complications</subject><subject>Treatment Outcome</subject><subject>Upper Extremity</subject><issn>0393-5264</issn><issn>1971-3274</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpd0E1LxDAQBuAgiltX_4IEL54KadJ8HWVZV2HFi3suaZto1raJ-RD331txvXiagXl4mZkTUFSSVyXBvD4FBSKSlBSzegEuYtwjRAmp0TlYYCQxYUgUYNhFDZ2BMQejOg3XTxtoXID6Uw1ZJeumn2n2Xgc42LGF0auYbGfTAfY52OkVti7lwU55hMl92QmmNx2UP8C5jSm4dw39HKSnFC_BmVFD1FfHugS7-_XL6qHcPm8eV3fb0mPCU4kN11hQxhkTfYVQJQ1nSsq2pxxrIZAkBrOWdy1CpmadQUZWdY8Q43S-y5AluP3N9cF9ZB1TM9rY6WFQk3Y5NpwygQmmdJY3_-Te5TDNyzUCCYpnJWZ0fUS5HXXf-GBHFQ7N3xfJN2hcbsw</recordid><startdate>201004</startdate><enddate>201004</enddate><creator>Albani, Giovanni</creator><creator>Cimolin, Veronica</creator><creator>Galli, Manuela</creator><creator>Vimercati, Sara</creator><creator>Bar, Daniela</creator><creator>Campanelli, Laura</creator><creator>Gandolfi, Roberto</creator><creator>Lombardi, Remo</creator><creator>Mauro, Alessandro</creator><general>CIC Edizioni Internazionali</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BFMQW</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201004</creationdate><title>Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients</title><author>Albani, Giovanni ; Cimolin, Veronica ; Galli, Manuela ; Vimercati, Sara ; Bar, Daniela ; Campanelli, Laura ; Gandolfi, Roberto ; Lombardi, Remo ; Mauro, Alessandro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p237t-2f7e28567668d10019f76a99bd572e88093f26b7cb00f46cf0f914d00675923f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Botulinum Toxins, Type A - therapeutic use</topic><topic>Electromyography - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Muscle Spasticity - drug therapy</topic><topic>Muscle Spasticity - etiology</topic><topic>Neuromuscular Agents - therapeutic use</topic><topic>Pain Measurement</topic><topic>Range of Motion, Articular - drug effects</topic><topic>Severity of Illness Index</topic><topic>Stroke - complications</topic><topic>Treatment Outcome</topic><topic>Upper Extremity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Albani, Giovanni</creatorcontrib><creatorcontrib>Cimolin, Veronica</creatorcontrib><creatorcontrib>Galli, Manuela</creatorcontrib><creatorcontrib>Vimercati, Sara</creatorcontrib><creatorcontrib>Bar, Daniela</creatorcontrib><creatorcontrib>Campanelli, Laura</creatorcontrib><creatorcontrib>Gandolfi, Roberto</creatorcontrib><creatorcontrib>Lombardi, Remo</creatorcontrib><creatorcontrib>Mauro, Alessandro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Continental Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Functional neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Albani, Giovanni</au><au>Cimolin, Veronica</au><au>Galli, Manuela</au><au>Vimercati, Sara</au><au>Bar, Daniela</au><au>Campanelli, Laura</au><au>Gandolfi, Roberto</au><au>Lombardi, Remo</au><au>Mauro, Alessandro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients</atitle><jtitle>Functional neurology</jtitle><addtitle>Funct Neurol</addtitle><date>2010-04</date><risdate>2010</risdate><volume>25</volume><issue>2</issue><spage>103</spage><epage>107</epage><pages>103-107</pages><issn>0393-5264</issn><eissn>1971-3274</eissn><abstract>The clinical assessment of spasticity in stroke patients generally includes descriptive scales, such as the Modified Ashworth Scale (MAS) and the Global Pain Scale (GPS), however these may not be sufficiently sensitive to accurately detect improvements, especially at upper limb level; electromyography (EMG) may be the answer to this clinical requirement. The aim of this study was to quantify the effects of botulinum toxin type A (BTX) in treating upper extremity spasticity in stroke patients, using clinical evaluation (MAS and GPS) and EMG. Ten patients were assessed before, 30 days and 180 days after BTX injection using clinical evaluations and EMG. At 30 days all clinical measures improved significantly. Whereas MAS scores, after recording an improvement at the first evaluation session, were worse at the second assessment, GPS scores improved over time, both at the first and at the second evaluation session. A reduction of EMG activity was found 30 days after injections, in particular at baseline and during passive flexion movement. Our results demonstrated that measurement of EMG activity may be an effective means of detecting functional improvements and of monitoring the effects of treatment in post-stroke patients.</abstract><cop>Italy</cop><pub>CIC Edizioni Internazionali</pub><pmid>20923608</pmid><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0393-5264 |
| ispartof | Functional neurology, 2010-04, Vol.25 (2), p.103-107 |
| issn | 0393-5264 1971-3274 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_756823255 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Adult Aged Botulinum Toxins, Type A - therapeutic use Electromyography - methods Female Humans Longitudinal Studies Male Middle Aged Muscle Spasticity - drug therapy Muscle Spasticity - etiology Neuromuscular Agents - therapeutic use Pain Measurement Range of Motion, Articular - drug effects Severity of Illness Index Stroke - complications Treatment Outcome Upper Extremity |
| title | Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T20%3A39%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20surface%20EMG%20for%20evaluation%20of%20upper%20limb%20spasticity%20during%20botulinum%20toxin%20therapy%20in%20stroke%20patients&rft.jtitle=Functional%20neurology&rft.au=Albani,%20Giovanni&rft.date=2010-04&rft.volume=25&rft.issue=2&rft.spage=103&rft.epage=107&rft.pages=103-107&rft.issn=0393-5264&rft.eissn=1971-3274&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E756823255%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=808522328&rft_id=info:pmid/20923608&rfr_iscdi=true |